Add BrightSurf on Google Email

Synthetic peptide could reduce vascular problems associated with COVID-ARDS

Researchers have developed a synthetic peptide that could help reduce vascular problems associated with acute respiratory distress syndrome in COVID-19. The peptide, called TIP, works by binding to a subunit of the epithelial sodium channel, which helps maintain barrier function and prevent damage from viral proteins.

SourceMedical College of Georgia at Augusta University·JournalFrontiers in Immunology·DateOct 3, 2023

Understanding lung damage in patients with COVID-19

Researchers used a hamster model to study COVID-19 lung damage, discovering that the immune system's response plays a crucial role in disease progression. They found that certain cells involved in lung immunity ingest the virus, triggering an inflammatory response that can be brought under control by T cells.

SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalNature Communications·TypeNews article·DateAug 11, 2021

New remote-controlled 'smart' platform helps in cardiovascular disease treatment

Researchers developed a remote-controlled 'smart' platform to mimic natural extracellular matrix-mediated endothelialization. The platform uses shape-memory polymers and gold nanorods to direct programmed vascular endothelium remodeling in a temporally controllable manner, offering new possibilities for treating cardiovascular disease.

SourceChinese Academy of Sciences Headquarters·JournalNational Science Review·DateDec 3, 2019

Endothelium, heal thyself

The endothelium, a cellular layer lining blood vessels, has an efficient barrier function maintained by its ability to heal micro-wounds. New research shows that biomechanical signals trigger the recovery response, generating reactive oxygen species to close gaps and restore functionality.

SourceBeth Israel Deaconess Medical Center·JournalJournal of Cell Biology·DateMay 16, 2013